Info

Altus Biologics Inc. is a pharmaceutical company that uses its powerful and proprietary protein crystallization technology to develop innovative, orally delivered protein therapeutics. Altus' protein crystallization technology, known as CrystalomicsÔ, enables the rapid commercialization of high-value orally delivered protein-based products by creating highly stable protein therapeutics. The technology enables oral delivery of the protein to the gastrointestinal tract to provide a localized or topical effect within the gastrointestinal lumen. Through its branded products portfolio, the Company's vision is to be the worldwide leader in the rapid and efficient development of valuable orally delivered proteins for the treatment of gastrointestinal and metabolic diseases. The Company has a series of products in various stages of research and development, all leveraging the Crystalomics technology. Altus' protein crystallization technology is also proving to be a valuable tool for parenteral delivery of proteins by allowing them to be delivered in a more patient friendly manner and also allowing controlled release formulations to reduce the number of injections. Altus has numerous development partners and is constantly evaluating the opportunity to expand its product development efforts through partnering opportunities.